Dave Singh Selected Research

Nebulizers and Vaporizers (Inhaler)

1/2023	Mortality Risk and Serious Cardiopulmonary Events in Moderate-to-Severe COPD: Post Hoc Analysis of the IMPACT Trial.
12/2022	Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis.
3/2022	Correction to: Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study.
1/2022	Higher COPD Assessment Test Score Associated With Greater Exacerbations Risk: A Post Hoc Analysis of the IMPACT Trial.
1/2022	Single inhaler triple therapy (SITT) in asthma: Systematic review and practice implications.
1/2022	Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial.
1/2022	New Perspectives on Chronic Obstructive Pulmonary Disease.
1/2022	Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone.
6/2021	Triple Versus Dual Combination Therapy in Chronic Obstructive Pulmonary Disease in Asian Countries: Analysis of the IMPACT Trial.
3/2021	Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dave Singh Research Topics

Disease

261	Chronic Obstructive Pulmonary Disease (COPD) 05/2024 - 01/2007
88	Asthma (Bronchial Asthma) 12/2023 - 07/2007
52	Inflammation (Inflammations) 05/2024 - 08/2006
19	Pneumonia (Pneumonitis) 01/2024 - 05/2009
13	COVID-19 09/2023 - 01/2020
9	Chronic Bronchitis 01/2023 - 10/2016
7	Infections 01/2023 - 07/2014
7	Dyspnea (Shortness of Breath) 01/2020 - 01/2012
6	Necrosis 07/2022 - 02/2014
5	Disease Progression 10/2023 - 01/2017
5	Emphysema 01/2021 - 06/2011
4	Respiratory Tract Diseases (Respiratory Tract Disease) 10/2021 - 01/2012
4	Obstructive Lung Diseases (Obstructive Lung Disease) 03/2021 - 01/2017
4	Headache (Headaches) 01/2020 - 01/2011
4	Lung Diseases (Lung Disease) 01/2019 - 02/2010
3	Respiratory Hypersensitivity 01/2021 - 01/2019
3	Virus Diseases (Viral Diseases) 07/2020 - 07/2014

Drug/Important Bio-Agent (IBA)

101	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 10/2008
58	Bronchodilator Agents (Bronchodilators)IBA 01/2024 - 01/2007
53	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2009
40	Formoterol Fumarate (Oxis)FDA Link 01/2023 - 01/2011
36	Muscarinic AntagonistsIBA 01/2023 - 01/2012
31	GoldIBA 10/2023 - 10/2009
25	CytokinesIBA 12/2023 - 05/2008
25	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 04/2022 - 01/2012
23	Beclomethasone (Beclometasone)FDA Link 01/2024 - 03/2012
23	GSK573719IBA 10/2023 - 08/2015
23	vilanterolIBA 10/2023 - 08/2015
20	fluticasone furoate FDA Link 12/2023 - 05/2018
18	Tiotropium Bromide (Spiriva)FDA Link 03/2021 - 08/2010
16	Proteins (Proteins, Gene)FDA Link 08/2022 - 01/2009
13	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 02/2009
12	GlucocorticoidsIBA 07/2023 - 09/2008
12	Phosphodiesterase 4 InhibitorsIBA 01/2023 - 03/2010
12	p38 Mitogen-Activated Protein KinasesIBA 08/2021 - 02/2009
11	Budesonide (Pulmicort)FDA LinkGeneric 12/2023 - 11/2014
11	Anti-Bacterial Agents (Antibiotics)IBA 09/2022 - 10/2012
10	Interleukin-13IBA 05/2024 - 01/2010
10	SmokeIBA 01/2019 - 05/2008
9	Monoclonal AntibodiesIBA 05/2024 - 10/2008
8	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2024 - 08/2006
8	SteroidsIBA 07/2023 - 11/2007
8	tanimilastIBA 01/2023 - 01/2019
8	AllergensIBA 01/2020 - 11/2007
8	LipopolysaccharidesIBA 01/2018 - 02/2009
7	Interleukin-8 (Interleukin 8)IBA 12/2023 - 05/2009
7	Interleukin-6 (Interleukin 6)IBA 12/2023 - 01/2009
7	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2023 - 10/2014
7	indacaterolIBA 02/2022 - 01/2011
7	Fluticasone (Cutivate)FDA LinkGeneric 01/2022 - 07/2007
7	aclidinium bromideIBA 01/2021 - 10/2012
7	tiotropium-olodaterolIBA 01/2021 - 10/2015
7	LigandsIBA 08/2019 - 02/2014
6	ensifentrineIBA 12/2023 - 11/2013
6	InterleukinsIBA 09/2023 - 08/2015
6	Interleukin-17 (Interleukin 17)IBA 12/2022 - 05/2011
6	Albuterol (Salbutamol)FDA LinkGeneric 04/2022 - 10/2012
6	Salmeterol Xinafoate (Serevent)FDA Link 01/2021 - 07/2007
6	Methacholine Chloride (Methacholine)FDA Link 01/2020 - 10/2012
5	Oxygen (Dioxygen)IBA 01/2023 - 11/2014
5	Heparin (Liquaemin)FDA LinkGeneric 01/2023 - 01/2020
5	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 11/2022 - 11/2009
5	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 11/2021 - 10/2016
5	RoflumilastIBA 11/2021 - 10/2016
5	16S Ribosomal RNAIBA 01/2021 - 01/2017
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2009
4	Janus Kinase InhibitorsIBA 01/2023 - 10/2016
4	ChemokinesIBA 11/2019 - 05/2008
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019 - 01/2013
4	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 08/2015 - 01/2011
3	Interleukin-4 (Interleukin 4)IBA 05/2024 - 08/2022
3	dupilumabIBA 05/2024 - 01/2023
3	Interleukin-33IBA 12/2023 - 01/2022
3	Interleukin-5 (Interleukin 5)IBA 12/2023 - 01/2018
3	benralizumabIBA 01/2023 - 12/2019
3	MacrolidesIBA 01/2023 - 10/2016
3	nezulcitinibIBA 01/2023 - 10/2021
3	AntioxidantsIBA 10/2022 - 01/2018
3	InterferonsIBA 08/2022 - 06/2019
3	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 08/2022 - 08/2019
3	Interleukin-2 (IL2)IBA 08/2022 - 12/2015
3	AZD-8871IBA 01/2022 - 01/2019
3	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2014
3	IronIBA 12/2021 - 01/2020
3	EnzymesIBA 12/2021 - 01/2017
3	Phosphotransferases (Kinase)IBA 11/2021 - 01/2016
3	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2021 - 09/2014
3	Mometasone Furoate (Nasonex)FDA LinkGeneric 04/2021 - 04/2020
3	Immunoglobulin E (IgE)IBA 01/2021 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2019
3	budesonide-glycopyrrolate-formoterol fumarate drug combinationIBA 01/2021 - 10/2019
3	doramapimodIBA 01/2020 - 01/2017
3	Chemokine ReceptorsIBA 11/2017 - 10/2008

Therapy/Procedure

96	Therapeutics 01/2024 - 10/2008
39	Nebulizers and Vaporizers (Inhaler) 01/2023 - 07/2007
7	Metered Dose Inhalers (Metered Dose Inhaler) 01/2022 - 01/2017
5	Drug Therapy (Chemotherapy) 10/2023 - 03/2012
4	Precision Medicine 12/2023 - 01/2016
3	Biological Therapy 01/2023 - 01/2021
3	Dry Powder Inhalers 01/2021 - 01/2019